tbuckley/cabot-search huggingface dataset:
49533 308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis
Authors: Yoshiko Niimura, Masahiro Kamata, Takeko Ishikawa, Mayumi Nagata, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Azusa Hiura, Kotaro Hayashi, Yayoi Tada
Journal: Journal of the American Academy of Dermatology (2024)
52833 A 1% selenium disulfide-based shampoo is as beneficial as 2% ketoconazole shampoo to manage moderate to severe scalp seborrheic dermatitis: a comparative randomized clinical trial
Authors: Daniel Fernandes-Melo, Serg Vañó-Galván, Anna Veriato, Vimi Lutchmanen-Kolanthan, Beatriz Sant'Anna, Stéphanie Leclerc-Mercier, Victoria Barbosa, Pascal Reygagne
Journal: Journal of the American Academy of Dermatology (2024)
53942 Tapinarof Cream 1% Once Daily in Adults and Children Down to 2 Years of Age with Moderate to Severe Atopic Dermatitis in Two Phase 3 Trials: Patient-reported Outcomes
Authors: Eric L. Simpson, Adelaide A. Hebert, Howard Sofen, John Browning, Philip M. Brown, Anna M. Tallman, Stephen C. Piscitelli, David S. Rubenstein
Journal: Journal of the American Academy of Dermatology (2024)
54092 The Development of Treatment Guidelines for Acne Vulgaris During Pregnancy and Lactation: A Delphi Consensus Study
Authors: Sophia Ly, Ahana Gaurav, Allison Yan, Eric Xia, Priya Manjaly, Kanika Kamal, Ali Shields, John Barbieri, Arash Mostaghimi
Journal: Journal of the American Academy of Dermatology (2024)
52137 The Effects of Botulinum Toxin Injections on Mood and Mood Disorders: A Systematic Review of Randomized Controlled Trials
Authors: Leah Johnston, Amy Zeglinski-Spinney, Samiha Mohsen, Darshana Seeburruth, Sophie Khaslavsky, Susan Poelman, Ilya Mukovozov
Journal: Journal of the American Academy of Dermatology (2024)
54560 A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region
Authors: Megan M. Tran, Guixing Wei, Lauryn Orsillo, Fatima N. Mirza, Sara Yumeen, Taylor Arnoff, Aakash Mehta, Oliver J. Wisco
Journal: Journal of the American Academy of Dermatology (2024)
51624 “I’m PSO Over COPD”: The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Psoriasis Patients in the U.S.
Authors: Sara N. Bilimoria, Kaviyon Sadrolashrafi, Robin Kikuchi, Danielle K. Yee, Audrey Hao, Rebecca K. Yamamoto, Hannah C. Tolson, Lily Guo, April W. Armstrong
Journal: Journal of the American Academy of Dermatology (2024)
54203 VISIBLE: Clearance and Symptom Improvement With Guselkumab at Week 16 in Skin of Color Participants With Moderate-to-Severe Plaque Psoriasis
Authors: Linda Stein Gold, Jensen Yeung, Adrian O. Rodriguez, Jessica Vasquez, Olivia Choi, Katelyn Rowland, Theodore Alkousakis, Jenny Jeyarajah, Javier Alonso-Llamazares, Stephen Tyring, April W. Armstrong
Journal: Journal of the American Academy of Dermatology (2024)
52186 Use of Artificial Intelligence to Optimize Translated Skin Cancer Prevention Patient Handouts
Authors: Helen Park, Sydney Dong, Sijia Zhang, Vy Xuan Pham, Jessica De La Rosa, Andres Cedeno, Anika Jallorina, Monica Guirgus, Bryan Sun, Regina Wang, George Hightower
Journal: Journal of the American Academy of Dermatology (2024)
50229 Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidyl peptidase-4 inhibitor-related bullous pemphigoid
Authors: Shoya Suzuki, Masahiro Kamata, Takeko Ishikawa, Hideaki Uchida, Teruo Shimizu, Yoshiki Okada, Makoto Ito, Ayu Watanabe, Azusa Hiura, Yayoi Tada
Journal: Journal of the American Academy of Dermatology (2024)
51253 Successful treatment of porokeratosis with topical two percent simvastatin cream in monotherapy: a case series of nine patients
Authors: Sara Pilar Herrero-Ruiz, Laura Fernández de la Fuente, Dolores Arias Palomo, Begoña Echeverría García, Helena Álvarez-Garrido, Alberto Guerrero Torija, Maria de la Soledad Vallejo-Ruiz, Jesús Borbujo
Journal: Journal of the American Academy of Dermatology (2024)
52238 Updated integrated safety analysis of ritlecitinib over 36 months in patients with alopecia areata (AA) from the ALLEGRO clinical trial program
Authors: Maryanne Senna, Peter Foley, Marni Wiseman, Ruaa Al Harithy, Cheng Zhou, Edward Nagy, Dalia Wajsbrot, Alexandre Lejeune, Robert Wolk, Samuel Zwillich
Journal: Journal of the American Academy of Dermatology (2024)
53113 Trifarotene shown to improve acne and related sequelae (scars, pigmentation)
Authors: Andrew Alexis, Stephen Schleicher, Jonathan Weiss, Valerie Callender, J.P. York, Rajeev Chavda, Fran E. Cook Bolden, Neal Bhatia, James Del Rosso, Linda Stein Gold
Journal: Journal of the American Academy of Dermatology (2024)
52250 Spacing of injection period of dupilumab in adult atopic dermatitis patients : A retrospective cohort study
Authors: Hyungrye Noh, Heeyeon Kim, Yeon Joo Jung, Jai Hee Bae, Byeonghyun Joo, Joonho Shim, Se Oh, Jihye Park, Dongyoun Lee, Jong Hee Lee
Journal: Journal of the American Academy of Dermatology (2024)
53648 A Distinct Subtype of Eosinophilic Folliculitis Following Hematopoietic Cell Transplantation
Authors: Alyce Kuo, Arpita Bose, Melissa Pulitzer, Stephen Dusza, Susan Prockop, Andrew Harris, Doris Ponce, Michael Scordo, Alina Markova
Journal: Journal of the American Academy of Dermatology (2024)
53086 The Impact of Dupilumab on Psychological Well Being in Moderate-to-Severe Atopic Dermatitis Patients: a Phase IV Clinical Trial
Authors: Kareem Elhage, Riley Spencer, Joy Jin, Samuel Yeroushalmi, Mimi Chung, Erin Bartholomew, Mitchell Davis, Marwa Hakimi, Wilson Liao, Tina Bhutani
Journal: Journal of the American Academy of Dermatology (2024)
54237 Treating Platysma Prominence with OnabotulinumtoxinA: Safety and Efficacy Results from a Phase 3 Multicenter, Randomized, Double-blind, Placebo-Controlled Study
Authors: Sabrina Fabi, Brian Biesman, Rosalyn George, Shannon Humphrey, Brenda LaTowsky, Robert Weiss, Grace S. Park, Warren Tong, Elisabeth Lee, René Hopfinger
Journal: Journal of the American Academy of Dermatology (2024)
50550 2-Week Application of Topical Colloidal Oatmeal Gel Cream Supports the Growth of Skin Commensal Staphylococcus Epidermidis in Subjects with Mild-to-Moderate Atopic Dermatitis
Authors: Nicole Comito, Judy Nebus, Katie Spisak, Jipsha Thakrar, Nikoleta Batchvarova
Journal: Journal of the American Academy of Dermatology (2024)
51898 VISIBLE: Guselkumab Demonstrates Significant Skin Clearance in Skin of Color Participants With Moderate-to-Severe Plaque Psoriasis Regardless of Baseline Inflammatory Disease Burden
Authors: Pearl Grimes, Seemal R. Desai, Adrian O. Rodriguez, Olivia Choi, Katelyn Rowland, Daphne Chan, Jenny Jeyarajah, Tina Bhutani, Joseph F. Merola, Alice B. Gottlieb
Journal: Journal of the American Academy of Dermatology (2024)
51349 Spesolimab for the prevention of generalized pustular psoriasis (GPP) flares in White/Caucasian patients: Results from the randomized, placebo-controlled Effisayil 2 study
Authors: Bruce Strober, Richard B. Warren, Kenneth B. Gordon, Richard G. Langley, Mark G. Lebwohl, Luis Puig, Ming Tang, Tatjana Radic, Patrick Hofmann, Christian Thoma, Diamant Thaçi
Journal: Journal of the American Academy of Dermatology (2024)
52241 Secukinumab demonstrates low immunogenicity in patients with moderate-to-severe hidradenitis suppurativa: Results from placebo-controlled, double-blind, Phase 3 SUNSHINE and SUNRISE trials
Authors: Martina Porter, Gerard Bruin, Manisha Saxena, Magdalena B. Wozniak, Shoba Ravichandran, Angela Llobet Martinez, Lorenz Uhlmann, Anna Passera, Nicolas Thomas, Alexa B. Kimball
Journal: Journal of the American Academy of Dermatology (2024)
52101 Shedding light on MC1R: Unraveling Gene Variants in Lentigo Maligna-type Melanoma Predisposition among the Utah Population
Authors: Annabelle Huntsman, Amanda Jiang, Carly Becker, Bing-Jian Feng, Douglas Grossman, Deborah Neklason, Robert L. Judson-Torres, Dekker Deacon
Journal: Journal of the American Academy of Dermatology (2024)
53461 5-Year Risk of Skin Cancer in Inflammatory Bowel Disease Patients treated with Vedolizumab versus Tumor Necrosis Factor-α Antagonists
Authors: Isabella Camacho, Haig Pakhchanian, Rahul Raiker, Lauren Crow, Melissa Pugliano-Mauro
Journal: Journal of the American Academy of Dermatology (2024)

Background: Tumor necrosis factor-α (TNFα) antagonists are commonly used for the management of patients with moderate-to-severe inflammatory bowel diseases (IBD). Although the data is controversial, TNFα antagonists have been associated with increased risk of cutaneous malignancies. Vedolizumab, a gut-selective monoclonal antibody, is a newer agent used for treating IBD; however, analysis of the long-term risk for malignancy remains understudied. The objective of this study is to assess the risk of cutaneous malignancy between TNFα antagonists and vedolizumab.
50543 Upadacitinib Improves Atopic Dermatitis-Related Nighttime Itch and Reduces Sleep Disturbance: Analysis of Time Spent in Response State From the Integrated Phase 3 Measure Up 1/2 Clinical Trials
Authors: Andrew Blauvelt, Vimal H. Prajapati, Sonja Ständer, Andrew E. Pink, Pedro Herranz-Pinto, Gil Yosipovitch, Wan-Ju Lee, Brian M. Calimlim, Andrew M. Platt, Jonathan I. Silverberg
Journal: Journal of the American Academy of Dermatology (2024)
50855 TID Dosing of Propranolol Leads to Improvement in Sleep Patterns in Patients Being Treated for Infantile Hemangiomas
Authors: Jackson Green, Jessica Nye, Chioma Obinero, Kelly Turner, Kate Richardson, Autumn Atkinson, Matthew Dallo, Alexander Jafari, Matthew Greives, Adelaide Hebert
Journal: Journal of the American Academy of Dermatology (2024)
52490 A multi-center, retrospective, chart review to evaluate the safety of poly-L-lactic acid injectable implant when used in non-facial areas
Authors: Kalpna Kay Durairaj, Ali Vafa, Shino Bay Aguilera, Sabrina Fabi, Neil Sadick, Melanie Palm, Jennifer Levine, Jennifer Levine, Sachin M. Shridharani, Flor Mayoral, Daniel Bråsäter, Inna Prygova
Journal: Journal of the American Academy of Dermatology (2024)
54630 2-Mercaptonicotinoyl Glycine: A new molecule that prevents and decreases UV-induced pigmentation
Authors: Delphine Kerob, B. Muller, F. Flament, J. Qiu, C. Tricaud, H. Jouni, Y. Wang, D. Amar, C. Delaunay
Journal: Journal of the American Academy of Dermatology (2024)
52273 Dupilumab Provides Sustained Normalization of Skin Barrier Function in Children With Moderate-to-Severe Atopic Dermatitis
Authors: Michael J. Cork, Evgeny Berdyshev, Elena Goleva, Simon G. Danby, Irina Bronova, Joseph Zahn, Inoncent Agueusop, Shantanu Bafna, Peck Ong, Annie Zhang, Donald Y.M. Leung
Journal: Journal of the American Academy of Dermatology (2024)
52251 Remibrutinib reduces CSU symptoms and rescue medication use in patients with chronic spontaneous urticaria despite absence of background medication
Authors: Lee Clore, Warner Carr, Jeffrey Tillinghast, Vipul Jain, John Reed, Petra Staubach, None Dr, Karine Lheritier, Pauline Walsh, Ivan Nikolaev, Sibylle Haemmerle, Ana Maria Giménez-Arnau
Journal: Journal of the American Academy of Dermatology (2024)
50483 Hepatitis B Vaccine Response in Psoriasis: Assessing the Impact of Immunosuppressive Treatments
Authors: William Nahm, E. Liang, Roger Ho
Journal: Journal of the American Academy of Dermatology (2024)

Biologic and systemic immunosuppressive therapies have significantly enhanced the treatment of psoriasis. However, these treatment modalities increase the risk of infections, notably hepatitis B virus (HBV), among patients. It is unclear how the immunogenicity of the HBV vaccination is affected in psoriasis patients on immunosuppressive therapies. We conducted a cross-sectional retrospective chart review of 71 adult patients with moderate-to-severe psoriasis who initially lacked immunity to HBV and later received at least one dose of the HBV vaccine. Before HBV vaccination, thirty-eight patients were initiated on some form of immunosuppressive therapy, with 28 patients on biologic monotherapy and 10 on a biologic combined with a disease-modifying antirheumatic drug [DMARD]. The post-vaccination HBV surface antibody (HBsAb) levels among patients on and off any immunosuppressive therapy (median 72.0IU/L vs. 28.3IU/L); were found to be similar (p=0.35). The percentage of patients with post-vaccination HBsAb levels ≥10IU/L (i.e., the seroprotection rate) (57.9% for those on therapy vs. 60.6% for those off) was also similar (p=0.82). Multivariate analysis revealed lower HBsAb levels among patients on combination therapy when compared to those on no immunosuppressive therapy (p=0.04). There was no difference in the odds of achieving seroprotective levels by immunosuppressive therapy status (any) or type (biologic monotherapy or combination) when compared to none (OR=0.79, OR=1.09, and OR=0.15; p=0.76, p=0.92, and p=0.10, respectively). In conclusion, the efficacy and seroprotection rates following HBV vaccination are consistent among psoriasis patients, irrespective of their therapy status or type, suggesting flexibility in vaccination timing for non-immune patients after starting therapy.
52784 Bimekizumab impact on pain in moderate to severe hidradenitis suppurativa: Week 48 results from BE HEARD I &amp; II
Authors: Lauren A.V. Orenstein, Vivian Shi, Hadar Lev-Tov, Errol Prens, Hideki Fujita, Jérémy Lambert, Robert Rolleri, Paulatsya Joshi, Edward Muller, Jacek C. Szepietowski
Journal: Journal of the American Academy of Dermatology (2024)
49781 Lived Experience of Hirsutism in Transgender Individuals: A Qualitative Study
Authors: Sarah Gold, Marta Taye, Rebecca Leibowitz, Francisco Delgado, Meron Siira, Vin Tangpricha, J. Sonya Haw, Jason Schneider, Michael Goodman, Howa Yeung
Journal: Journal of the American Academy of Dermatology (2024)
52792 Lebrikizumab provides stable skin response with no or minimal fluctuations for up to two years in patients with atopic dermatitis
Authors: Jonathan Sliverberg, Andreas Wollenberg, Peter Lio, Jose Manuel Carrascosa, Marta Casillas, Gaia Gallo, Yuxin Ding, Fan Emily Yang, Christian Vestergaard, Linda Stein Gold, James Del Rosso
Journal: Journal of the American Academy of Dermatology (2024)
53351 Predictors of drug survival in patients with hidradenitis suppurativa treated with TNF-alpha-inhibitors
Authors: Albert Young, Kathy Lu, Andrea Dai, Dheeraj Kagithala, Eglal Samir, Mark Gregory, Madison Romanski, Peter Dimitrion, Iltefat Hamzavi, Qing-Sheng Mi
Journal: Journal of the American Academy of Dermatology (2024)
53025 Roflumilast cream 0.3% in patients with psoriasis: Improvement in patient reported outcomes and pruritus from two pooled phase 3 trials (DERMIS-1/DERMIS-2)
Authors: Mark Lebwohl, Chih-Ho Hong, Leon Kircik, Jennifer Soung, Melinda Gooderham, Angela Moore, James Del Rosso, Irina Turchin, David Krupa, Robert Higham, David Berk
Journal: Journal of the American Academy of Dermatology (2024)
50668 Long-term Impact of Apremilast on Cardiometabolic Parameters and the Relationship of Cardiometabolic Changes With Psoriasis Efficacy
Authors: Bruce Strober, Jeffrey Crowley, Richard Langley, Cynthia Deignan, Lichen Teng, Zhenwei Zhou, Nehal Mehta
Journal: Journal of the American Academy of Dermatology (2024)
52924 A Randomized Clinical Trial Evaluating Online versus In-Person Care for Patients with Atopic Dermatitis: The Impact on Quality of Life
Authors: April W. Armstrong, Minnelly Luu, Gina Kostandy, Robin Kikuchi, Audrey Hao, Nicholas Rosen, Farzana Choudhury, Danielle Yee, Jason Doctor, Joel M. Gelfand, Mary-Margaret Chren
Journal: Journal of the American Academy of Dermatology (2024)
52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
Authors: Brett King, Arash Mostaghimi, Manabu Ohyama, Maryanne Senna, Chiara Chiasserini, Yves Dutronc, Chunyuan Liu, Guanglei Yu, Mwangi Murage, Rodney Sinclair
Journal: Journal of the American Academy of Dermatology (2024)
50804 Low-Dose Oral Minoxidil Initiation and Monitoring (LOMI) For Hair Loss: A Modified Delphi Consensus of Experts
Authors: Yagiz Matthew Akiska, Jennifer Fu, Paradi Mirmirani, Ingrid Roseborough, Erin Mathes, Tina Bhutani
Journal: Journal of the American Academy of Dermatology (2024)
54476 Assessing the Accuracy, Usefulness, and Readability of Artificial-Intelligence-Generated Responses to Common Dermatologic Surgery Questions: A Double-Blinded Comparative Study of ChatGPT, Google Bard, and the American College of Mohs Surgery
Authors: Michelle A. Robinson, Micah Belzberg, Sach Thakker, Kristin Bibee, Emily Merkel, Deborah F. MacFarlane, Jordan Lim, Jeffrey Scott, Min Deng, T. Y. Alvin Liu, Elise Ng
Journal: Journal of the American Academy of Dermatology (2024)
50577 Benefits of a Colloidal Oatmeal Cream with Biomimetic Lipid Combination and Beta Glucan Active in Atopic Dermatitis in Brazilian Multi-Ethnic Patients: Instrumental, Clinical, Microbiome, Images, and Patient-Perception
Authors: Isabelle Rennó, Suellen Rennó, Ana Luísa Teixeira, Joyce Pires, Tamara Carneiro, Maria Carolina Semprini, Lais Lopes, Rocio Orozco, Tania Cestari
Journal: Journal of the American Academy of Dermatology (2024)
52971 Association between Isotretinoin Usage and Inflammatory Bowel Disease Incidence: A Meta-Analysis and Systematic Review
Authors: Areeba Ahmed, Eric Koza, Melissa Ma, Misha Haq, Victoria Shi, Michael D. Yi, Umer Nadir, Brian A. Cahn, Ross Pearlman, Daniel I. Schlessinger, Murad Alam
Journal: Journal of the American Academy of Dermatology (2024)
53954 Ratification of the IDEOM (International Dermatology Outcome Measures) MSK-Q: a new tool for measuring musculoskeletal symptoms across the psoriatic disease spectrum
Authors: Arianna Zhang, Lourdes Perez-Chada, Michael Woodbury, Gretchen Ball, Melissa Zundell, April Armstrong, Vibeke Strand, Alice B. Gottlieb, Joseph F. Merola
Journal: Journal of the American Academy of Dermatology (2024)
53999 Efficacy and safety after 52 weeks in psoriasis patients switching to risankizumab after suboptimal response to secukinumab or ixekizumab – a subgroup analysis
Authors: Richard B. Warren, Antonio Costanzo, Neil Korman, Simone Rubant, Nadia Ibrahim, Yanbing Zheng, Vassilis Stakias, Diamant Thaçi
Journal: Journal of the American Academy of Dermatology (2024)
50290 Gasdermins are involved in the pathogenesis of psoriasis – the study on human tissue, serum, and urine.
Authors: Julia Nowowiejska, Anna Baran, Justyna Hermanowicz, Anna Pryczynicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak
Journal: Journal of the American Academy of Dermatology (2024)
50865 Efficacy of Step-up Abrocitinib Treatment in Combination With Topical Medicated Therapy for Treating Atopic Dermatitis Flares: A Post Hoc Analysis of the JADE REGIMEN Trial
Authors: Jonathan I. Silverberg, Eric L. Simpson, Melinda J. Gooderham, Pinaki Biswas, Gary Chan, Urs Kerkmann, Erman Güler
Journal: Journal of the American Academy of Dermatology (2024)
53632 Development and Validation of Gene Expression Panel Test for Cutaneous Squamous Cell Carcinoma
Authors: Jacob Kechter, Angelina Hwang, Alysia Hughes, Xing Li, Nan Zhang, Richard Butterfield, Steven Nelson, Emma Johnson, Leah Swanson, Javier Cañueto, Aaron Mangold
Journal: Journal of the American Academy of Dermatology (2024)
53971 Correlation of Vitiligo Area Scoring Index With Vitiligo Extent Score-plus Responses in a Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Phase 2b Study
Authors: Nanja van Geel, Andrew Blauvelt, Amit G. Pandya, Thierry Passeron, Kurt Brown, Lois Erskine, Zhenyi Xue, Khaled Ezzedine
Journal: Journal of the American Academy of Dermatology (2024)
53357 Evaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral Minoxidil Therapy
Authors: Colin Kincaid, Ajay Sharma, Brynn Sargent, Irmina Gradus-Pizlo, Elizabeth Dineen, Natasha Mesinkovska
Journal: Journal of the American Academy of Dermatology (2024)
53225 Gammopathic Dermopathy of MGUS: Unraveling the Mysterious Gamut of Unrelated Scenarios
Authors: Emily R. Gordon, Caroline Chen, Oluwaseyi Adeuyan, Brigit A. Lapolla, Lauren M. Fahmy, Celine M. Schreidah, Megan H. Trager, Larisa J. Geskin
Journal: Journal of the American Academy of Dermatology (2024)
54233 Duration of response rates per best overall response to sonidegib 200 mg in patients with locally advanced basal cell carcinoma: results of the 42-month BOLT study
Authors: Michael Migden, Caroline Robert, Axel Hauschild, James Spencer, Nicholas Squittieri, Kunal Patel, Ramon Arntz, Serena Martelli, Joerg Dierlamm, Aaron Farberg
Journal: Journal of the American Academy of Dermatology (2024)
52632 Emerging Cat-related Cutaneous Sporotrichosis in Thailand: A Retrospective Cohort Study of Clinical Presentations, Antifungal Susceptibility, and Treatment Outcomes
Authors: Phuwakorn Saengthong-aram, Penvadee Pattanaprichakul, Sumanas Bunyaratavej, Pattriya Jirawattanadon, Piriyaporn Chongtrakool, Waratchaya Panjapakkul, Suthasanee Prasertsook, Nicha Wareesawetsuwan, Charussri Leeyaphan
Journal: Journal of the American Academy of Dermatology (2024)
54153 Consistent utilization of the 40-gene expression profile (40-GEP) test in high-risk cutaneous squamous cell carcinoma (cSCC) by clinicians according to intended use indications
Authors: Jane Yoo, Anesh Prasai, Alison L. Fitzgerald, Aaron S. Farberg, Matthew S. Goldberg
Journal: Journal of the American Academy of Dermatology (2024)
51362 Overall effectiveness of Risankizumab in special areas and the impact on quality of life; 1-year real world data from the German cohort of the VALUE study
Authors: Thomas Stavermann, Petra Staubach, Dariusch Mortazawi, Marius Schild, Kristina Lohmann, Diamant Thaçi
Journal: Journal of the American Academy of Dermatology (2024)
52027 Monoclonal Gammopathy of undetermined significance is not associated with increased risk of skin cancer: A population-based screening cohort study
Authors: Jonas A. Adalsteinsson, Gauti Kjartan Gislasson, Kelley Sharp, Sigrun Thorsteinsdottir, Saemundur Rognvaldsson, Ingunn Thorsteinsdottir, Isleifur Olafsson, Jon Kristinn Sigurdsson, Thorvardur Jon Love, Sigurdur Yngvi Kristinsson
Journal: Journal of the American Academy of Dermatology (2024)
49205 Development of and insights derived from SkinTracker, an integrated mobile health app and web portal enabling remote-friendly clinical research study of atopic dermatitis
Authors: Joy Jin, Kareem G. Elhage, Riley K. Spencer, David Wu, Marwa Hakimi, Mitchell S. Davis, Abhilash Kahlon, Paul Dhaliwal, Navdeep Dhaliwal, Tina Bhutani, Wilson Liao
Journal: Journal of the American Academy of Dermatology (2024)
50256 Psoriasis and Sleep Duration: A Cross-Sectional Study Using National Health and Nutrition Examination Surveys (NHANES) 2009-2014
Authors: None Mallory deCampos-Stairiker, Stephanie Radoslovich, Aine Huntington, Alex Ortega Loayza, Sarah Andrea, Arielle Hernandez
Journal: Journal of the American Academy of Dermatology (2024)
52486 Quantification of IL-10 soluble levels in patients with Basal Cell Carcinoma and the relationship with socio-demographic features in Mexican population
Authors: María José Zorrilla Marina, Emmanuel Valdés Alvarado, Marisol Ramírez Padilla, Raul Gerardo Méndez Flores, Marianella Zambrano Román, Eddie Gibson Martínez Peña
Journal: Journal of the American Academy of Dermatology (2024)
51661 “Insurance Card Please”: A Population-Based Study on Delayed and Inaccessible Care Among United States Psoriasis Patients
Authors: Kaviyon Sadrolashrafi, Robin Kikuchi, Danielle K. Yee, Audrey Hao, Rebecca K. Yamamoto, Hannah C. Tolson, Sara N. Bilimoria, April W. Armstrong
Journal: Journal of the American Academy of Dermatology (2024)
52655 Impact of hidradenitis suppurativa on patients' work and productivity: Results from the HS Uncovered global patient survey
Authors: Joslyn S. Kirby, Philippe Guillem, Eva Vilarrasa, Ivette Alarcon, Mei Go, Gillian Newbold, Aikaterini Mamareli, Craig Richardson, Barry McGrath, Georgios Kokolakis
Journal: Journal of the American Academy of Dermatology (2024)